Produktbild: Cancer Theranostics, Second Edition

Cancer Theranostics, Second Edition

215,99 €

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

29.09.2025

Herausgeber

Xiaoyuan Chen + weitere

Verlag

Elsevier Science & Technology

Seitenzahl

550

Maße (L/B/H)

27,9/21,6/3 cm

Gewicht

1551 g

Auflage

2. Auflage

Sprache

Englisch

ISBN

978-0-443-22253-5

Beschreibung

Portrait

Xiaoyuan (Shawn) Chen, PhD, is a Senior Investigator and Chief of the Laboratory of Molecular Imaging and Nanomedicine (LOMIN) at the National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institutes of Health (NIH). He is also founding editor of journal Theranostics. He holds a PhD in Chemistry from the University of Idaho.Dr. Zhang is Assistant Professor (Tenure Track) at the Yong Loo Lin School of Medicine, National University of Singapore. She has published more than 50 peer-reviewed articles (more than 15 peer-reviewed articles in top-ranking journal JNM) in the most reputed scientific journals in the respective field. She was awarded the prestigious Thomas O'Dorisio Young Investigator Award (only 1 awardee every two years world-wide), one of TOP thirty early career professionals who stand out as "Ones to Watch” by the SNMMI, as well as Majd-Gilday Investigator Award from SNMMI, etc., and serves on the editorial board of Clin Nucl Med (IF 10.782) and is the only editorial board member from Singapore. She currently serves as Dean of Research of International Centers for Precision Oncology (ICPO) Academy, GermanyStephen T.C. Wong, PhD (Computer Science), PE (Electrical Engineering), is John S. Dunn Distinguished Endowed Chair of Biomedical Engineering at Houston Methodist Hospital, the Founding Chair of Department of Systems Medicine and Bioengineering at Houston Methodist Research Institute, and a Professor of Radiology, Neurosciences, Pathology, and Laboratory Medicine at Weill Cornell Medical College.

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

29.09.2025

Herausgeber

Verlag

Elsevier Science & Technology

Seitenzahl

550

Maße (L/B/H)

27,9/21,6/3 cm

Gewicht

1551 g

Auflage

2. Auflage

Sprache

Englisch

ISBN

978-0-443-22253-5

EU-Ansprechpartner

Kolibri 360 GmbH
Ettore-Bugatti-Straße 6-14
51149 Köln
DE
produktsicherheit@kolibri360.de

Herstelleradresse

Elsevier Science & Technology
London Wall 125
EC2Y 5AS London
GB
tradeorders@elsevier.com

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

Die Leseprobe wird geladen.
  • Produktbild: Cancer Theranostics, Second Edition
  • 1. Cancer theranostics - An updated introduction

    Part 1: In Vitro Diagnostics
    2. Tissue specimen and liquid biopsy testing for cancer diagnostics
    3. Circulating tumor cells and cancer associated fibroblasts in IVD of cancer
    4. Extracellular vesicle-based IVD of cancer
    5. Non-coding RNAs in cancer diagnosis
    6. Circulating tumor DNA technology in cancer diagnosis
    7. Nanotechnology in IVD of cancer

    Part 2: Anatomical, Functional and Molecular Imaging in Cancer Theranostics
    8. Radionuclide imaging of cancer
    9. Luminescence imaging of cancer
    10. MRI and MPI of cancer
    11. Ultrasound and photoacoustic imaging of cancer
    12. Raman spectroscopy and imaging for cancer diagnosis
    13. OCT and OCE of cancer
    14. Artificial intelligence in cancer imaging

    Part 3 Image-Guided Cancer Therapy
    15. Image-guided radiation therapy (IGRT) of cancer
    16. Image-guided surgery (IGS) of cancer
    17. Image-guided thermal ablation of cancer
    18. Image-guided cancer drug delivery

    Part 4: Theranostics Platforms
    19. Radiotheranostics
    20. Magnetotheranostics
    21. Immunotheranostics
    22. Optotheranostics
    23. Sonotheranostics
    24. RNA theranostics
    25. DNA theranostics

    Part 5: Production, regulations and translations of theranostics
    26. Scale-up production of theranostic formulas
    27. Clinical translation and regulations of theranostics